AVROBIO is a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose.
  • TickerAVRO
  • ISINUS05455M1009
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

David Nierengarten ...
  • Jeffrey La Rosa

Plato at Center of AVRO Universe

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

David Nierengarten ...
  • Jeffrey La Rosa

Plato at Center of AVRO Universe

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ValuEngine Rating and Forecast Report for AVRO

ResearchPool Subscriptions

Get the most out of your insights

Get in touch